We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Simple Single-Drop Test for Vitamin B12 Deficiency Developed

By LabMedica International staff writers
Posted on 04 Nov 2014
Researchers have developed a novel method, requiring only a single drop of blood, to test for vitamin B12 deficiency that is sensitive enough to work on anyone, including newborn babies.

Vitamin B12 deficiency can now be tested with a single drop of blood collected from a finger prick, and then simply blotted and dried overnight on a test card consisting of filter paper. More...
Researchers from University of British Columbia (UBC; Vancouver, BC, Canada) led by Prof. Yvonne Lamers, developed the dried blood spot card analysis to be sensitive enough to measure the amount of methylmalonic acid (MMA), indicator of B12 level. “This minimally invasive approach helps us measure deficiency in an easier and more convenient way, especially in large samples of people,” says Prof. Lamers, “Our method is the first to make dried blood spot analysis sensitive enough to test healthy people for B12 deficiency.”

The new method has the potential to be added to BC's Newborn Screening Program, which tests for treatable disorders in all infants born in BC. B12 deficiency, if not detected and treated early, can cause delayed brain development, slow learning, and digestion problems. Treatment includes injections, supplements, or dietary change. “We are interested in Dr. Lamers’ method, which may be sensitive enough to detect and confirm B12 deficiency using the blood spot cards currently collected on BC newborns,” says Hilary Vallance, director of the BC Newborn Screening Program. Roughly 5% of Canadian adults are B12 deficient and 20% show marginal sufficiency, according to Statistics Canada. In developing countries, deficiency is as high as 50% to 80% of the population.

The method also simplifies blood sample collection and testing in rural or remote areas where sophisticated lab equipment is unavailable. It is currently being used in a research project in rural Indonesia.

The study, published by Schroder TH et al. in the October 1, 2014 issue of the Journal of Nutrition, involved testing the new method on 94 healthy young women in Vancouver.

Related Links:

University of British Columbia 



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Specimen Radiography System
TrueView 200 Pro
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.